ArticleCancer biology & therapy2026

Opsonization and timing as key determinants of MBTA immunotherapy efficacy in pancreatic adenocarcinoma and recurrence treatment.

Andrea Frejlachova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.